You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

Abbott India gains after good Q2 results

Capital Market 

rose 4.02% to Rs 4,884.45 at 14:52 on after net profit rose 23.17% to Rs 75.02 crore on 12.63% increase in net sales to Rs 721.14 crore in Q2 September 2016 over Q2 September 2015.

The result was announced during trading hours today, 28 November 2016.

Meanwhile, the Sensex was up 77.44 points, or 0.29%, to 26,393.78.

On BSE, so far 1,581 shares were traded in the counter, compared with average daily volume of 3,053 shares in the past one quarter. The stock hit a high of Rs 4,918.95 and a low of Rs 4,675 so far during the day. The stock hit a 52-week high of Rs 6,050 on 31 December 2015. The stock hit a 52-week low of Rs 4,360 on 13 June 2016. The stock had outperformed the market over the past 30 days till 25 November 2016, rising 0.50% compared with the 5.73% decline in the Sensex. The scrip had also outperformed the market in past one quarter, falling 0.75% as against Sensex's 5.28% decline.

The large-cap company has equity capital of Rs 21.25 crore. Face value per share is Rs 10.

India, a subsidiary of US-based Laboratories, offers medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Abbott India gains after good Q2 results

Abbott India rose 4.02% to Rs 4,884.45 at 14:52 IST on BSE after net profit rose 23.17% to Rs 75.02 crore on 12.63% increase in net sales to Rs 721.14 crore in Q2 September 2016 over Q2 September 2015.

rose 4.02% to Rs 4,884.45 at 14:52 on after net profit rose 23.17% to Rs 75.02 crore on 12.63% increase in net sales to Rs 721.14 crore in Q2 September 2016 over Q2 September 2015.

The result was announced during trading hours today, 28 November 2016.

Meanwhile, the Sensex was up 77.44 points, or 0.29%, to 26,393.78.

On BSE, so far 1,581 shares were traded in the counter, compared with average daily volume of 3,053 shares in the past one quarter. The stock hit a high of Rs 4,918.95 and a low of Rs 4,675 so far during the day. The stock hit a 52-week high of Rs 6,050 on 31 December 2015. The stock hit a 52-week low of Rs 4,360 on 13 June 2016. The stock had outperformed the market over the past 30 days till 25 November 2016, rising 0.50% compared with the 5.73% decline in the Sensex. The scrip had also outperformed the market in past one quarter, falling 0.75% as against Sensex's 5.28% decline.

The large-cap company has equity capital of Rs 21.25 crore. Face value per share is Rs 10.

India, a subsidiary of US-based Laboratories, offers medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Abbott India gains after good Q2 results

rose 4.02% to Rs 4,884.45 at 14:52 on after net profit rose 23.17% to Rs 75.02 crore on 12.63% increase in net sales to Rs 721.14 crore in Q2 September 2016 over Q2 September 2015.

The result was announced during trading hours today, 28 November 2016.

Meanwhile, the Sensex was up 77.44 points, or 0.29%, to 26,393.78.

On BSE, so far 1,581 shares were traded in the counter, compared with average daily volume of 3,053 shares in the past one quarter. The stock hit a high of Rs 4,918.95 and a low of Rs 4,675 so far during the day. The stock hit a 52-week high of Rs 6,050 on 31 December 2015. The stock hit a 52-week low of Rs 4,360 on 13 June 2016. The stock had outperformed the market over the past 30 days till 25 November 2016, rising 0.50% compared with the 5.73% decline in the Sensex. The scrip had also outperformed the market in past one quarter, falling 0.75% as against Sensex's 5.28% decline.

The large-cap company has equity capital of Rs 21.25 crore. Face value per share is Rs 10.

India, a subsidiary of US-based Laboratories, offers medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders and primary care.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard